Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Assets
Cash and cash equivalent	$ 11,499,136	$ 4,923,515
Restricted cash	3,248,271	0
Accounts receivable	162,586	109,366
Deferred offering costs	0	33,164
Insurance and security deposits	95,000	749,454
Other current assets	1,061,520	313,812
Total current assets	16,066,513	6,129,311
Property and equipment, net	5,265	8,425
Intangible assets, net	372,592	80,031
Other assets	0	95,000
Total assets	16,444,370	6,312,767
Liabilities and Stockholders’ Equity (Deficit)
Accounts payable	5,567,233	2,275,559
Accrued liabilities	2,877,438	4,359,348
Insurance reserve	2,330,190	2,113,039
Note payable, current portion	0	1,554,548
Deferred revenue	52,192	76,059
Total current liabilities	10,827,053	10,378,553
Note payable, net of current portion	0	444,627
Total liabilities	10,827,053	10,823,180
Commitments and contingencies (Note 3)	0	0
Stockholders’ equity (deficit):
Preferred stock, 15,000,000 shares authorized, par value $0.00001, 0 shares issued and outstanding as of December 31, 2021 and 2020, respectively	0	0
Common stock, 50,000,000 shares authorized, par value $0.00001, 21,609,409 and 17,741,713 shares issued and outstanding as of December 31, 2021 and 2020, respectively	216	177
Additional paid-in capital	75,806,853	39,725,445
Accumulated deficit	(70,189,752)	(44,236,035)
Total stockholders’ equity (deficit)	5,617,317	(4,510,413)
Total liabilities and stockholders’ equity (deficit)	$ 16,444,370	$ 6,312,767